DEA warns of deadly drug mix fueling national crisis

December 07, 2024 | Veterinary Medical Board, Boards and Commissions, Executive, California

Thanks to Scribe from Workplace AI and Family Portal , all articles about California are free for you to enjoy throughout 2025!


DEA warns of deadly drug mix fueling national crisis

This article was created by AI using a video recording of the meeting. It summarizes the key points discussed, but for full details and context, please refer to the video of the full meeting. Link to Full Meeting

On December 7, 2024, the Veterinary Medical Board of California held a webinar focused on the critical issue of drug diversion in veterinary practices. The meeting highlighted the growing concern over the misuse of controlled substances and the need for effective prevention strategies.

Drug diversion refers to the illegal use of medications that are meant for legitimate medical purposes. This issue is particularly prevalent in healthcare settings, including veterinary practices, where access to controlled substances is easier. The board discussed the importance of identifying patterns of losses in medications and understanding the potential for diversion.

The webinar presented a list of commonly diverted medications, emphasizing opioids as the most frequently misused drugs. Other substances of concern included stimulants, benzodiazepines, and certain sedatives. The board referenced the latest DEA National Drug Threat Report, which identified amphetamines, pain relievers, and sedatives as the top misused prescription medications.

A significant focus was placed on specific drugs trending in illicit use within veterinary medicine. Ketamine, a controlled substance used as an anesthetic, has seen increased diversion. The board noted its popularity in party scenes and its street names, such as \"Special K.\"

Another drug discussed was Xylazine, a powerful sedative approved only for veterinary use. Although not federally controlled, its illicit use has surged, especially when mixed with fentanyl, leading to dangerous outcomes. The board warned that naloxone, typically used to reverse opioid overdoses, is ineffective against Xylazine.

The meeting also touched on other substances like metomidine and gabapentin, which have been linked to rising fatalities. Gabapentin, in particular, has shown a troubling increase in misuse, especially when combined with opioids.

The Veterinary Medical Board urged veterinarians to treat these drugs with the same caution as controlled substances. They recommended implementing tracking logs and secure storage practices to prevent theft and misuse.

Overall, the webinar underscored the urgent need for vigilance in veterinary practices to combat drug diversion and protect public health.

Converted from Veterinary Medical Board Inspection Webinar - November 14, 2024 meeting on December 07, 2024
Link to Full Meeting

Comments

    View full meeting

    This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

    View full meeting

    Sponsors

    Proudly supported by sponsors who keep California articles free in 2025

    Scribe from Workplace AI
    Scribe from Workplace AI
    Family Portal
    Family Portal